Corrigendum: Immobilization of Growth Factors for Cell Therapy Manufacturing.

cell product manufacturing cell therapy cost-of-goods growth factor immobilization stem cell factor

Journal

Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513

Informations de publication

Date de publication:
2020
Historique:
received: 24 06 2020
accepted: 26 06 2020
entrez: 9 9 2020
pubmed: 10 9 2020
medline: 10 9 2020
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fbioe.2020.00620.].

Identifiants

pubmed: 32903834
doi: 10.3389/fbioe.2020.00821
pmc: PMC7438897
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

821

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2020 Enriquez-Ochoa, Robles-Ovalle, Mayolo-Deloisa and Brunck.

Auteurs

Daniela Enriquez-Ochoa (D)

Tecnologico de Monterrey, School of Engineering and Science, FEMSA Biotechnology Center, Monterrey, Mexico.

Pedro Robles-Ovalle (P)

Tecnologico de Monterrey, School of Engineering and Science, FEMSA Biotechnology Center, Monterrey, Mexico.

Karla Mayolo-Deloisa (K)

Tecnologico de Monterrey, School of Engineering and Science, FEMSA Biotechnology Center, Monterrey, Mexico.

Marion E G Brunck (MEG)

Tecnologico de Monterrey, School of Engineering and Science, FEMSA Biotechnology Center, Monterrey, Mexico.

Classifications MeSH